| 生物活性 | |||
|---|---|---|---|
| 描述 | Yonkenafil (Tunodafil), a novel phosphodiesterase 5 (PDE5) inhibitor, effectively reduces cerebral infarction, neurological deficits, edema, and neuronal damage in affected areas. It may enhance cognitive function through neurogenesis modulation and potentially treats Alzheimer's disease[1]. | ||
| 实验方案 | |||
|---|---|---|---|
| 1mg | 5mg | 10mg | |
|
1 mM 5 mM 10 mM |
2.05mL 0.41mL 0.21mL |
10.25mL 2.05mL 1.03mL |
20.51mL 4.10mL 2.05mL |
| 参考文献 |
|---|